Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 10
Submit an article Journal homepage
1,124
Views
0
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability

Francesco OddoneGlaucoma Unit, IRCSS-Fondazione Bietti, Roma, ItalyCorrespondence[email protected]
View further author information
Pages 1259-1268 | Received 13 May 2022, Accepted 10 Oct 2022, Published online: 26 Oct 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.